No Detail Found!

Interferon Alpha Receptors and Stat1 as Therapy Predictors of a Sustained Virological Response in Hepatitis C/b Co-infection.

Author(s)
Maleha Asim Department of Biochemistry, Foundation University Medical College,
Amir Rashid Department of Biochemistry, Army Medical College, NUMS, Islamabad, Pakistan
Saleem Ahmed Khan Department of Pathology, Army Medical College, NUMS, Islamabad,
Abstract
Objective: To determine the expression of interferon alpha receptors 1 and 2 along with signal transducer and activator of transcription-1 in peripheral blood mononuclear cells of both hepatitis C mono-infected and hepatitis C and B co-infected patients, and to assess whether these targeted genes predict sustained virological response to interferon therapy. Methods: This cross-sectional study was carried out at the Army Medical College, Rawalpindi, Pakistan, from January 2012 to December 2015, and comprised hepatitis C mono-infected and hepatitis C and B co-infected patients. The patients were divided into groups 1 and 2. Group-1a and group-2a consisted of mono-infected and co-infected sustained responders, while group-1b and group-2b had mono-infected and co-infected non-sustained responders. Peripheral blood mononuclear cells from healthy controls were also quantified for these subunits. Target gene expressions were studied by retro-transcription of respective messenger ribonuclieic acid extracted from the cells followed by polymerase chain reaction amplification. Results: Of the 191 subjects, there were 20(10.5%) in group-1a, 35(18.3%) in group-2a, 65(34%) in group-1b and 51(26.7%) in group-2b. The remaining 20(10.5%) were controls. Overall, 106 (55.5%) were males and 85 (44.5%) were females. Interferon alpha receptor 1 expression in groups 1a and 2a was significantly higher compared to groups 1b (p=0.018) and 2b (p=0.031). Signal transducer and activator of transcription-1 protein expression showed no significant difference (p=0.062 and p=0.519). No difference in expression was measured between the two sets of groups with regard to interferon alpha receptor 2 expression (p=0.278 and p=0.590). Conclusion: Our results show that levels of IFNAR-1 mRNA expression may be a good predictor for IFN-related anti-viral activity in both HCV mono-infected and HCV/HBV co-infected patients.
Publication Details
Page(s) 1572-1577
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 11, Year: 2018

Request the full text from PASTIC

Keywords
Interferon alpha receptor, Interferon alpha receptor, Interferon alpha receptor, Interferon alpha receptor, Inter feron therapy response, Hepatitis B virus, Signal transducer and activator of transcription
References
OjeOJ,SuleWF,FamurewaD., 2012.Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria,VImmunol 25 448 -55
ZhangJ,NguyenD,HuKQ, 2016.Chronic hepatitis C virus infection: a review of current direct-acting antiviral treatment strategies,N Am J Med Sci (Boston) 9 47 -54
ZhaoLJ,HeSF,LiuY,ZhaoP,BianZQ,QiZT, 2016.Inhibition of STAT pathway impairs anti-hepatitis C virus effect of interferon alpha,Cell Physiol Biochem 40 77 -90
El-SaadanyS,ZiadaDH,BassatHE,FarragW,El-SerogyH,EidM, 2013.The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy,Can J Gastroenterol Hepatol 27 e13 -e7
AzizH,RazaA,IrfanJ, 2016.Optimum predictors of therapeutic outcome in HCV patients in Pakistan,J Med Virol 88 100 -8
IdreesM,Riazuddin S, 2009.A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients,BMC Gastroenterol 9 5 -
GusattiCdS,CostiC,de MedeirosRM,HalonML,GrandiT,MedeirosAFR, 2016.Association between cytokine gene polymorphisms and outcome of hepatitis B virus infection in southern Brazil,J Med Virol 88 1759 -66
MengF,WangJ,GeJ,FanX,WangB,HanL, 2011.Alteration of interferon-?/? receptors in chronic hepatitis B patients,J Cin Immunol 31 521 -32
GoughDJ,MessinaNL,HiiL,GouldJA,SabapathyK,RobertsonAP, 2010.Functional crosstalk between type I and II interferon through the regulated expression of STAT1,PLoS Biol 8 e1000361 -
LemonSM, 2010.Induction and evasion of innate antiviral responses by hepatitis C virus,J Biol Ch em 285 22741 -7
SungPS,CheonH,ChoCH,HongSH,SeoHI,ParkSH, 2015.Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness,Proc Natl Acad Sci U S A 112 10443 -8
MarijanovicZ,RagimbeauJ,Van Der HeydenJ,UzéG,PellegriniS., 2007.Comparable potency of IFN?2 and IFN? on immediate JAK/STAT activation but differential down-regulation of IFNAR2,Biochem J 407 141 -51
LwangaSK,LemeshowS,OrganizationWH, 1991.Sample size determination in health studies: a practical manual, -
NdebeleP., 2013.The Declaration of Helsinki, 50 years later,JAMA 310 2145 -6
MetzP,ReuterA,BenderS,BartenschlagerR, 2013.Interferon-stimulated genes and their role in controlling hepatitis C virus,J Hepatol 59 1331 -41
IvashkivLB,DonlinLT, 2014.Regulation of type I interferon responses,Nat Rev Immunol 14 36 -49
ChandraPK,GunduzF,HazariS,KurtR,PanigrahiR,PoatB, 2014.Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis,PLoS One 9 e108616 -
DattaS,HazariS,ChandraPK,SamaraM,PoatB,GunduzF,VirolJ., 2011.Mechanism of HCV's resistance to IFN-? in cell culture involves expression of functional IFN-? receptor 1, 8 351 -
SalamaH,AttaHA,AbdelrazikH, 2007.Intrahepatic expression of interferon alpha & interferon alpha receptor m-RNA can be used as predictors to interferon response in HCV and HCC patients,Afr J Health Sci 14 86 -96
LevinD,SchneiderWM,HoffmannHH,YardenG,BusettoAG,ManorO, 2014.Multifaceted activities of type I interferon are revealed by a receptor antagonist,Sci Signal 7 ra50 -
MassirerKB,HirataMH,SilvaAEB,FerrazM,NguyenNY,HirataRDC, 2004.Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C,Braz J Med Biol Res 37 643 -7
RadaevaS,JarugaB,Won-HoK,HellerT,LiangTJ,BinG, 2004.Interferongamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C,Biochem J 379 199 -208
ChoIR,OhM,KohSS,MalilasW,SrisutteeR,JhunBH, 2012.Hepatitis B virus X protein inhibits extracellular IFN-?-mediated signal transduction by downregulation of type I IFN receptor,Int J Mol Med 29 581 -6
FukudaR,IshimuraN,HamamotoS,MoritaniM,UchidaY,IshiharaS, 2001.Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver,J Med Virol 63 220 -7
KonstantinouD,DeutschM., 2015.The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management, 28 221 -8
AsimM,RashidA,MajeedA,WahidM,RazakS,JamilA, 2017.Association of Interferon Alpha Receptor 1 with sustained virological response in hepatitis C and B co-infected patients,J Pak Med Assoc 67 980 -5
GaoB,WangH,LafdilF,FengD., 2012.STAT proteins-key regulators of antiviral responses, inflammation, and tumorigenesis in the liver,J Hepatol 57 430 -41
TaniguchiH,IwasakiY,TakahashiA,ShimomuraH,MoriyaA,YuPC, 2007.Interferon-Stimulated Genes in Genotype 1b Chronic Hepatitis C, 50 32 -9
0

Citations

0

Downloads

54

Views